To assess the immunological effects of treatment with Tα1 in combination with PCDs during HCMV infection, the expression of CD40, CD80, CD58, TIM-3 and HLA-DR mean fluorescence intensity (MFI) in DCs derived from PBMCs was analyzed using multiparametric flow cytometry. The gene discussed is CD58; the disease is cytomegalovirus infection.